Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPinewood Technologies Group Regulatory News (PINE)

Share Price Information for Pinewood Technologies Group (PINE)

Share Price is delayed by 15 minutes
Get Live Data
305.00    -2.00 (-0.65%)
Bid:
305.00
Ask:
306.50
Spread: 1.50 (0.492%)
Market Cap: £351.05m
PINE Live PriceLast checked at - London Stock Exchange

Intraday Pinewood Technologies Group Share Chart

Additional Listing & Total Voting Rights

17 Apr 2024 07:00

RNS Number : 8696K
Pinewood Technologies Group PLC
17 April 2024
 

17 April 2024

 

Pinewood Technologies Group PLC ("the Company")

 

Additional Listing & Total Voting Rights

 

A listing application has been made by the Company for 17 new Ordinary Shares (the "EBT Shares") to be admitted to the premium listing segment of the Official List and to trading on the London Stock Exchange's main market for listed securities ("Admission"). The EBT Shares will be issued fully paid and will rank pari passu in all respects with the existing issued Ordinary Shares. Admission is anticipated to occur on 18 April 2024. 

 

The EBT Shares are to be issued to Accuro Trustees (Jersey) Ltd, trustee of the Pendragon Employee Benefit Trust (the "EBT") and are required to ensure that the number of Ordinary Shares in issue is exactly divisible by 20 in order to effect the Capital Reorganisation.

Following the issue of the EBT Shares and Admission, the Company will have 1,742,312,420 Ordinary Shares, representing a total ordinary share capital of £87,115,621. The voting rights attached to the Ordinary Shares are on the basis of one vote per Ordinary Share, representing total voting rights of 1,742,312,420. There are no shares held in treasury.

 

This figure (1,742,312,420) may be used by Shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Capitalised terms used but not otherwise defined in this announcement have the same meaning given to them in the circular of the Company dated 5 April 2024.

 

Enquiries:

 

Jefferies International Limited (Financial Adviser and Joint Corporate Broker)

+44 (0) 20 7029 8000

Philip Noblet

Thomas Bective

Jordan Cameron

Headland Consultancy (PR & Communications)

+44 (0) 20 3805 4822

Henry Wallers

Jack Gault

 

Jefferies International Limited ("Jefferies"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting solely for the Company, and for no-one else, as broker in connection with the matters referred to in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice to any other person in relation to the content of this announcement or any other matters described in this announcement. To the fullest extent permitted by law, neither Jefferies nor any of its affiliates assumes any responsibility whatsoever for or makes any representation or warranty express or implied, in relation to the contents of this announcement, including its accuracy, completeness or verification or for any other statement made or purported to be made by it, or on its behalf and nothing contained in this announcement is, or shall be, relied upon as a promise or representation in this respect whether as to the past, present or future, in connection with the Company, the Group, or the matters referred to in this announcement. Jefferies and its affiliates accordingly disclaims to the fullest extent permitted by law all and any duty, responsibility and liability whether arising in tort, contract or otherwise which it might otherwise be found to have in respect of this announcement or any such statement or otherwise.

 

This announcement is not intended to, and does not constitute, or form part of, any offer to sell or an invitation to purchase or subscribe for any securities in any jurisdiction.

 

This announcement has been prepared for the purpose of complying with the applicable law and regulation of the United Kingdom and information disclosed may not be the same as that which would have been disclosed if this announcement has been prepared in accordance with the laws and regulations of jurisdictions outside the United Kingdom.

 

 

 

-ENDS-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSIFMFTMTABBRI
Date   Source Headline
1st Dec 20251:34 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSHolding(s) in Company*
20th Oct 20257:00 amRNSNotification pursuant to UKLR 6.4.8
14th Oct 20257:00 amRNSDirectorate Changes
25th Sep 20254:12 pmRNSDirector/PDMR Shareholding
25th Sep 202512:13 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNSHalf year results for the 6 months to 30 June 2025
15th Sep 20257:00 amRNSInclusion in FTSE 250 Index
11th Sep 20256:00 pmRNSWarehouse REIT
26th Aug 20255:26 pmRNSDirector/PDMR Shareholding
20th Aug 20257:00 amRNSHolding(s) in Company
4th Aug 202512:00 pmRNSCompletion of PWSA Business Acquisition
4th Aug 202511:41 amRNSHolding(s) in Company
4th Aug 20257:00 amRNSNotice of Interim Results
1st Aug 20259:00 amRNSHolding(s) in Company
31st Jul 20258:03 amRNSCompletion of Lithia JV Acquisition & Admission
30th Jul 20252:00 pmRNSAdmission of New Ordinary Shares
28th Jul 20257:00 amRNSAmendment of Acquisition Agreement
25th Jul 20253:35 pmRNSDirector/PDMR Shareholding
7th Jul 202511:28 amRNSDirector/PDMR Shareholding
7th Jul 20257:00 amRNSAcquisition of Pinewood South Africa Business
1st Jul 20253:23 pmRNSHolding(s) in Company
30th Jun 20254:10 pmRNSResults of AGM & General Meeting
27th Jun 20254:13 pmRNSDirector/PDMR Shareholding
12th Jun 20252:40 pmRNSDirector/PDMR Shareholding
6th Jun 20253:38 pmRNSPublication of Prospectus
6th Jun 20257:00 amRNSAcquisition of Lithia’s Stake in North America JV
4th Jun 202512:00 pmRNSBoard composition update
28th May 20257:00 amRNSDirector/PDMR Shareholding
29th Apr 20257:00 amRNSSignificant New Contract Award
28th Apr 20252:51 pmRNSDirector/PDMR Shareholding
17th Apr 202511:29 amRNSPublication of the Annual Report & Accounts FY24
1st Apr 20257:00 amRNSFinal Results
28th Mar 20259:00 amRNSDirector/PDMR Shareholding
28th Mar 20259:00 amRNSDirector Declaration
20th Mar 20254:24 pmRNSNotice of Results
3rd Mar 20252:00 pmRNSIssue of Seez Consideration Shares
27th Feb 20257:00 amRNSDirector/PDMR Shareholding
25th Feb 20251:54 pmRNSDirector/PDMR Shareholding
25th Feb 202512:00 pmRNS-RCommencement of Trading on OTCQX in the U.S.
21st Feb 20257:00 amRNSResult of Equity Fundraise
20th Feb 20254:40 pmRNSRetailBook Offer
20th Feb 20254:36 pmRNSEquity Fundraise
20th Feb 20254:35 pmRNSProposed Acquisition of Seez
14th Feb 20257:00 amRNSSignificant New Contract Award and Trading Update
12th Feb 202511:10 amRNSHolding(s) in Company
28th Jan 202512:09 pmRNSDirector/PDMR Shareholding
30th Dec 20247:00 amRNSPDMR Transaction Notification
20th Dec 20244:46 pmRNSHolding(s) in Company
26th Nov 202412:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.